Jovana Nikolic is an Assistant Editor at KALTBLUT. She focuses on various aspects of medicine and healthcare, including medical specialties, diagnostics, and healthcare technology, with particular interests in hematology, immunology, and oncology. Jovana's work has been featured in KALTBLUT, Infectious Disease Advisor, and Dermatology Advisor.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jovana Nikolic's articles primarily focus on medical research, clinical trials, genetic disorders, rare diseases, and treatment options. She often cites data and uses press releases as sources.
Given her focus on these areas, pitches should provide insights into recent medical research findings, updates on ongoing or upcoming clinical trials for rare diseases or genetic disorders. Additionally, experts with a deep understanding of the development of novel treatments would likely capture Jovana’s interest.
As she does not have a specified geographic focus but covers topics that are global in nature (medical research and clinical trials), relevant information from any location could be suitable for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Genotyping revealed high RH allele diversity among Kenyan blood donors, including RHCE variants affecting high- and low-prevalence antigen expression.
By: Jovana Nikolic
Cold-stored platelet subpopulations intermediate 1 (Int1) and intermediate 2 (Int2) may develop characteristics of both aggregatory and procoagulant platelets, making them more effective in the treatment of conditions such as fetal and neonatal alloimmune thrombocytopenia (FNAIT), according to a study presented at the 30th Congress of the European Hematology Association (EHA 2026), held between June 11 and 14, 2026, in Milan, Italy.
| Publish Date The LoVAS regimen for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) management provides very
| Publish Date Neonatal diseases, such as fetal and neonatal alloimmune thrombocytopenia (FNAIT), remain a major cause of mortality
Fc gamma receptor III (FcγRIII)-dependent phagocytosis might be a dominant mechanism of platelet destruction in fetal and neonatal alloimmune thrombocytopenia (FNAIT), according to a study preprint published in Blood Advances
| Publish Date Combining serology, RHD/RHCE genotyping, and Duffy phenotyping in admixed populations can detect partial D alleles
| Publish Date The German antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patient-reported outcome (AAV-PRO) questionnaire
| Publish Date Three intronic single-nucleotide variations (SNVs) may aid the identification of the clinically significant
| Publish Date A combination of 3 routine serological tests may help identify newborns with hemolytic disease of the fetus and
The total bilirubin-to-plasma total protein (TB/pTP) ratio can serve as an indicator of bilirubin-induced neurotoxicity in neonatal hyperbilirubinemia, often
